Back to Search

AUPH

Aurinia Pharmaceuticals Inc
Data: 2026-09-04
$16.08
Price
-0.25%
Change
$19.25
52W High
$10.34
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options
Quick Stats
Sep 04, 2026

46.7

AI Score

HOLD

0.47

Volume Ratio

TBA

Next Earnings

11

+ve Days (30d)

19

-ve Days (30d)

AUPH Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

AUPH Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

AUPH Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

AUPH Daily Out of Money Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

AUPH Daily In the Money Options - Sort by Max open Interest (near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

AUPH Most Active Options by Volume(near term)

5th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track
AUPH Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

AUPH Stock Summary

Last updated Sep 04, 2026

AUPH is currently trading at $16.08, positioned above its 200-day moving average of $15.49, indicating a long-term uptrend. The stock has a 52-week range of $10.34 to $19.25.

Technical Analysis: The 50-day moving average stands at $15.85, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 50.993, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.011, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates AUPH at 46.7/100 with a HOLD recommendation.

AUPH (Aurinia Pharmaceuticals Inc) Indicators

Last updated Sep 04, 2026

Indicator Value
RSI(14) 50.993
CMF (20) 0.011
ROC (10) -3.423
ADX (14) 24.053
Indicator Value
MACD (12,26,9) 0.151
AROONOSC (14) 21.429
WILLAMS %R (14) -64.908
MFI (14) 43.573

Aurinia Pharmaceuticals Inc is above both the 50 Day and 200 Day SMA which is considered Bullish.

AUPH Moving Averages Analysis

Aurinia Pharmaceuticals Inc has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Sep 04, 2026

Aurinia Pharmaceuticals Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Sep 04, 2026

AUPH (Aurinia Pharmaceuticals Inc) Simple Moving Averages

Moving Averages are last updated Sep 04, 2026

Days MA
10 16.33
20 16.04
30 15.76
50 15.85
100 15.89
200 15.49

AUPH Fundamental Analysis

P/E (Forward) 11.2994
P/E (Trailing) 7.1327
Market Cap ($) 2.1 billion
Earnings/Share ($) 2.26
Net Profit Margin (%) 1.0084
Dividend/Share ($) --
EPS Estimate Current Year ($) 0.944
EPS Estimate Next Year ($) 1.0667
WallStreet Target Price ($) 17.86
Most Recent Quarter

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.